Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Yongzeng Wang"'
Autor:
Xiuyan Wang, Oriana Borquez-Ojeda, Jolanta Stefanski, Fang Du, Jinrong Qu, Jagrutiben Chaudhari, Keyur Thummar, Mingzhu Zhu, Ling-bo Shen, Melanie Hall, Paridhi Gautam, Yongzeng Wang, Brigitte Sénéchal, Devanjan Sikder, Prasad S. Adusumilli, Renier J. Brentjens, Kevin Curran, Mark B. Geyer, Sham Mailankhody, Roisin O’Cearbhaill, Jae H. Park, Craig Sauter, Susan Slovin, Eric L. Smith, Isabelle Rivière
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 22, Iss , Pp 377-387 (2021)
With the US Food and Drug Administration (FDA) approval of four CD19- and one BCMA-targeted chimeric antigen receptor (CAR) therapy for B cell malignancies, CAR T cell therapy has finally reached the status of a medicinal product. The successful manu
Externí odkaz:
https://doaj.org/article/ac2a507ac1554df1b9bab28f312a4318
Autor:
Ying Wang, Xudong Wei, Dongmei Yan, Cheng Zhang, Hongsheng Zhou, Chunrong Tong, Heng Mei, Jie Jin, Ting Niu, Aibin Liang, Jienan Ren, Yiping Deng, Wei Jin, Yi Feng, Lin Shi, Yongzeng Wang, Changting Haudenschild, Lulu Lv, Jianxiang Wang
Publikováno v:
Blood. 140:1598-1600
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8875c0c88c30a58b0134e632213ea7f
https://doi.org/10.1182/blood-2022-165002
https://doi.org/10.1182/blood-2022-165002
Autor:
Eric L. Smith, Brigitte Senechal, Craig S. Sauter, Jolanta Stefanski, Fang Du, Prasad S. Adusumilli, Susan F. Slovin, Ling-bo Shen, Devanjan S. Sikder, Jagrutiben Chaudhari, Kevin J. Curran, Renier J. Brentjens, Keyur Thummar, Yongzeng Wang, Melanie Hall, Xiuyan Wang, Isabelle Riviere, Roisin E. O'Cearbhaill, Mark B. Geyer, Sham Mailankhody, Mingzhu Zhu, Jae H. Park, Paridhi Gautam, Jinrong Qu, Oriana Borquez-Ojeda
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 22, Iss, Pp 377-387 (2021)
With the US Food and Drug Administration (FDA) approval of four CD19- and one BCMA-targeted chimeric antigen receptor (CAR) therapy for B cell malignancies, CAR T cell therapy has finally reached the status of a medicinal product. The successful manu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8739f0be124b233e9fc279ed0e72e837
http://www.sciencedirect.com/science/article/pii/S2329050121001169
http://www.sciencedirect.com/science/article/pii/S2329050121001169
Cross-Compatible Embedding and Semantic Consistent Feature Construction for Sketch Re-identification
Publikováno v:
Proceedings of the 30th ACM International Conference on Multimedia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fcea36704a9fbb5498f200f884e8d252
https://doi.org/10.1145/3503161.3548224
https://doi.org/10.1145/3503161.3548224
Autor:
Yu Zhang, Ying Wang, Runxia Gu, Lin Shi, Yongzeng Wang, Yi Feng, Lulu Lv, Qing Rao, Min Wang, Jianxiang Wang
Publikováno v:
Blood. 140:630-631
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41812cd1bae54d5ac430344eee067f9b
https://doi.org/10.1182/blood-2022-162345
https://doi.org/10.1182/blood-2022-162345
Autor:
Ying Wang, Xiaojuan Chen, Shuning Wei, Yingchang Mi, Lin Shi, Yongzeng Wang, Changting Haudenschild, Lulu Lv, Xiaofan Zhu, Jianxiang Wang
Publikováno v:
Blood. 138:2811-2811
Background: The incidence of B-cell ALL follows a bimodal distribution, with the first peak occurring in childhood and a second peak occurring around the age of 50. While the prognosis for pediatric patientshas improved over the past decades, prognos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fc2d133cf98b22be791ac209b9f109a
https://doi.org/10.1182/blood-2021-145272
https://doi.org/10.1182/blood-2021-145272
Autor:
Craig S. Sauter, Sergio Giralt, Ahmet Dogan, Renier J. Brentjens, Xiuyan Wang, Kevin J. Curran, Yvette Bernal, Ashvin N. Singh, Craig H. Moskowitz, Jae H. Park, Brigitte Senechal, Malloury Hall, Terence J. Purdon, Victoria Szenes, Michel Sadelain, Ai Ni, Isabelle Riviere, Sarah Yoo, Matthew J. Matasar, Miguel-Angel Perales, Yongzeng Wang
Publikováno v:
Blood
High-dose chemotherapy followed by autologous stem cell transplantation (HDT-ASCT) is the standard of care for relapsed or chemorefractory diffuse large B-cell lymphoma (rel/ref DLBCL). Only 50% of patients are cured with this approach. We investigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1b1b7c11bfdf746d55f04610e8be18c
https://europepmc.org/articles/PMC6695562/
https://europepmc.org/articles/PMC6695562/
Autor:
Brigitte Senechal, Meier Hsu, Elizabeth Halton, Jae H. Park, M. Lia Palomba, Isabelle Riviere, Terence J. Purdon, Yongzeng Wang, Dayenne G. van Leeuwen, Renier J. Brentjens, Xiuyan Wang, Mark B. Geyer, Michel Sadelain, Sean M. Devlin, Yvette Bernal
Publikováno v:
JCI insight. 5
BACKGROUND: Subgroups of patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) exhibit suboptimal outcomes after standard therapies, including oral kinase inhibitors. We and others have previously reported on the safety and ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f4df34cfef0b42ef90d062f6f26cbf0
https://pubmed.ncbi.nlm.nih.gov/30938714
https://pubmed.ncbi.nlm.nih.gov/30938714
Autor:
Jinghua Piao, Brittany N. Dubose, Claire Henchcliffe, Susan Zabierowski, Wong Karen, Shannon Mann, Kiran Ramnarine, Abderrahman El Maarouf, Nidia L Claros, Craig Fredrickson, Callie Horn, Sonja Kriks, Stefan Irion, Mark J. Tomishima, Brent Safford, Urs Rutishauser, Siera Rosen, Ellen J. Hill, Viviane Tabar, Isabelle Riviere, Lorenz Studer, Monalisa Navare, Vladimir P. Bermudez, Yongzeng Wang
Publikováno v:
Cell stem cell, vol 28, iss 2
Cell Reports Medicine
Cell Reports Medicine
Parkinson's disease is characterized by the loss of dopaminergic neurons in the substantia nigra leading to disabling deficits. Dopamine neuron grafts may provide a significant therapeutic advance over current therapies. We have generated midbrain do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba3232d501b73ac20cd20da031f5ea2e
https://doi.org/10.1016/j.stem.2021.01.004
https://doi.org/10.1016/j.stem.2021.01.004
Autor:
Elizabeth Halton, Brigitte Senechal, Meier Hsu, Jae H. Park, Renier J. Brentjens, Sean M. Devlin, Isabelle Riviere, Yongzeng Wang, Jürgen Rademaker, Nicole Lamanna, Xiuyan Wang, Mark B. Geyer, Michel Sadelain, Terence J. Purdon
Patients with residual chronic lymphocytic leukemia (CLL) following initial purine analog-based chemoimmunotherapy exhibit a shorter duration of response and may benefit from novel therapeutic strategies. We and others have previously described the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96eb461fa085c0aa4e6bccdaf90356a5
https://europepmc.org/articles/PMC6094824/
https://europepmc.org/articles/PMC6094824/